RO
Laboratorios Rovi
ROVI.MC·BMEMadrid ESFounded 19462,000 employees
Mid CappharmaPublicCardiologyInfectious Disease
Platform: Enoxaparin CDMO
Market Cap
$3B
All Drugs
3
Clinical Trials
8
Failed / Terminated
1
FDA Approved
1
Stock Price & Catalysts (ROVI.MC)
Loading ROVI.MC stock data...
Drug Pipeline (3 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Olpaglumide | ROV-5657 | Approved | 4 | KRASG12C | EpilepsyHNSCC | ||
| Terarelsin | ROV-463 | Phase 1/2 | 2 | TIGIT | ADPKDNMOSD | ||
| Ivonesiran | ROV-7968 | Phase 1/2 | 2 | CGRP | ObesityADPKD |
SEC Filings & Financial Documents
SEC filings are not available for BME-listed companies.
Laboratorios Rovi trades on BME (ES). SEC EDGAR only covers US-listed issuers.
Insider Trading Activity
Insider trading data is not available for non-US exchanges.
Catalyst Events (8)